Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressant drugs that treat depression and other mental health conditions by inhibiting the reabsorption of serotonin by neurons in the brain.
According to the National...
Because the past few centuries have witnessed several revolutionary scientific advances, research into the mechanisms responsible for infectious diseases and the development of drugs and vaccines has led to the eradication of...
Pfizer recently announced that David M. Denton will replace Frank D'Amelio as chief financial officer (CFO) and executive vice president of the company.
Before Pfizer, Denton served as...
AstraZeneca recently launched a global research and development Postdoctoral Challenge to help advance drug discovery for some of the world’s most complex diseases.
The challenge invites...
Clinical trials are an integral part of new product discovery and development. These trials (or clinical studies) test and assess potential treatments such as drugs, medical devices, or biologics (vaccines, gene and cellular therapies,...
Eli Lilly and Company recently launched an education campaign to educate, support, connect, and empower people diagnosed with early breast cancer (EBC) with a high risk of recurrence.
The campaign,...
AstraZeneca recently announced that its combination chemotherapy treatment improved radiographic progression-free survival (rPFS) compared to standard-of-care for metastatic castration-resistant...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently issued a positive opinion of Pfizer’s COVID-19 treatment, Paxlovid.
The CHMP recommended...
The National Institutes of Health (NIH) recently launched the first phase of Neuromod Prize, a $9.8 million competition to accelerate the development of neuromodulation therapies.
Neuromodulation...
The Center for Breakthrough Medicines (CBM) and the University of Pennsylvania Gene Therapy Program (GCP) recently collaborated to advance the discovery and manufacturing of gene therapies.
The...
AstraZeneca recently collaborated with Scorpion Therapeutics to discover, develop, and commercialize precision medicines against previously undruggable targets.
The companies will focus on a class of...
Johnson & Johnson Medical Device Companies (JJMDC) recently tapped Microsoft to expand its secure and compliant digital surgery ecosystem.
Microsoft Cloud will help JJDMC drive innovation that...
Pfizer and Biohaven recently completed a collaboration transaction to commercialize small molecule migraine drugs, rimegepant and zavegepant, outside the US.
Rimegepant, commercialized as Nurtex ODT...
Eli Lilly & Company recently acquired exclusive rights to Entos Pharmaceuticals’ Fusogenix nucleic acid delivery technology to develop nucleic acid products.
The companies will initially...
Novartis and Alnylam recently collaborated to leverage proprietary siRNA technology to develop liver-targeted therapy as an alternative to transplantation for patients experiencing liver...
Hackensack Meridian Health recently announced its support of the clinical development of a highly-differentiated immuno-oncology platform from Alloplex Biotherapeutics.
This investment is...
Pfizer recently entered into a $6.7 billion proposed pharma acquisition deal with Arena Pharmaceuticals to develop therapies for chronic disease management.
Arena Pharmaceutical’s...
Roche recently launched the AVENIO Edge System to advance next-generation sequencing (NGS) technologies.
Researchers can use the pre-analytical program for sequencing library preparation, target...
Roche and TIB Molbiol recently added three additional research use only test kits to detect mutations present in the Omicron COVID-19 variant.
The three test kits, VirSNip SARS Spike ins214EPE,...
AstraZeneca and VaxEquity recently collaborated to discover, develop, and commercialize a self-amplifying RNA (saRNA) therapeutics platform.
The long-term research collaboration aims to optimize...
